CP-286601
A detailed overview of the compound CP-286601
CP-286601 is a chemical compound that has been studied for its potential effects on the central nervous system. It is primarily known for its role as a selective antagonist of the 5-HT2C receptor, which is a subtype of the serotonin receptor family. This compound has been of interest in research related to psychiatric and neurological disorders.
Chemical Structure and Properties[edit | edit source]
CP-286601 is classified as a piperazine derivative. Its chemical structure consists of a piperazine ring bonded to an indole moiety and a dihydroindene group. The molecular formula of CP-286601 is C₁₈H₂₀N₂, and it has a molecular weight of 318.46 g/mol.
Pharmacology[edit | edit source]
CP-286601 acts as a selective antagonist at the 5-HT2C receptor. The 5-HT2C receptor is one of the several subtypes of serotonin receptors, which are involved in the modulation of neurotransmission in the brain. By blocking this receptor, CP-286601 can influence various physiological and psychological processes, including mood, anxiety, and appetite regulation.
Mechanism of Action[edit | edit source]
The mechanism by which CP-286601 exerts its effects involves the inhibition of serotonin binding to the 5-HT2C receptor. This receptor is a G protein-coupled receptor (GPCR) that, when activated by serotonin, can influence intracellular signaling pathways. By antagonizing this receptor, CP-286601 may alter the downstream effects of serotonin signaling, potentially leading to changes in mood and behavior.
Research and Potential Applications[edit | edit source]
Research on CP-286601 has primarily focused on its potential therapeutic applications in treating disorders such as depression, anxiety, and obesity. The compound's ability to modulate serotonin signaling makes it a candidate for further investigation in these areas.
Preclinical Studies[edit | edit source]
In preclinical studies, CP-286601 has been shown to affect feeding behavior and body weight in animal models, suggesting its potential use in the treatment of obesity. Additionally, its effects on mood regulation have been explored in the context of depression and anxiety models.
Safety and Toxicology[edit | edit source]
As with any investigational compound, the safety and toxicological profile of CP-286601 is an important consideration. Studies have been conducted to assess its potential side effects and toxicity in animal models, but comprehensive human safety data are not yet available.
Also see[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD